Quantcast Point Therapeutics Skyrockets Following Merger With Dara
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Point Therapeutics Skyrockets Following Merger With Dara

Posted on 10/10/2007 18:54 PM | Link | Post Comment
by H.S. Ayoub, DMD
BioHealth Investor



Point Therapeutics (POTP) jumped from a close of just over $0.04 a share on Tuesday to an intra-day high of $0.45 following news that privately held DARA Biosciences will take over the unsuccessful biotech in a reverse merger. The stock ended trading at $0.26, however, post-bell trading has it back up to $0.33

By reverse merging with Point DARA becomes a publically traded company, by-passing the extra costs and waiting period of filing for an IPO.

Point Therapeutics was trading for pennies following failure of its phase 3 clinicals for a lung cancer treatment earlier this year. DARA acquires the company along with its pipeline.

Watch shares of POTP tomorrow morning as it will sure be another wild open.



BioHealth Investor.com
________________________
Stock Quote or
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
Morpheus Trading - Thu Oct 02, 2008 08:58AM
NOTE: Please click on the charts below to enlarge them if [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.